Study Maps Cell Environment Around Early Breast Cancer
Researchers at MD Anderson Cancer Center charted the cells surrounding ductal carcinoma in situ, a common precancerous breast condition.
Updated on Nov. 13, 2026 in Cancer
Researchers at The University of Texas MD Anderson Cancer Center mapped more than 850,000 cells from normal breast tissue, ductal carcinoma in situ (DCIS) and invasive breast cancer. The study, published today in Science, identified cancer stromal loops, ring-like structures of supportive tissue and vascular cells that surround DCIS lesions.
Why it matters
DCIS is the most common form of preinvasive, or stage 0, breast cancer, and not all cases progress to invasive disease. Mammograms and other breast examinations have increased how often DCIS is detected, making it more important to understand which lesions are likely to advance.
The evidence is a single-cell and spatial profiling atlas built from more than 850,000 cells across normal breast tissue, DCIS and invasive breast cancer samples. The atlas does not yet show which DCIS lesions will progress to invasive disease, and researchers plan further work on that question.
The players
The University of Texas MD Anderson Cancer Center
A Houston-based cancer center within the University of Texas System that conducted the research and is among the leading cancer treatment and research institutions in the United States.
Nicholas Navin
A co-lead of the study and a researcher at MD Anderson who works on single-cell genomics methods for studying cancer.
Savitri Krishnamurthy
A co-lead of the study and a researcher at MD Anderson focused on breast pathology and the early stages of breast cancer.
The details
Using single-cell and spatial profiling technologies, the team generated a comprehensive atlas of the tumor microenvironment for DCIS. The mapping showed extensive changes in both cancer cells and the surrounding microenvironment as the disease progressed toward invasive cancer.
Timeline
- November 13, 2026: Study published in Science.
Health Landscape
The study follows the broader push to build cell-level atlases of tumors, including efforts such as the Human Tumor Atlas Network. Applying that approach to DCIS extends it to the preinvasive stage of breast cancer, which has received far less cellular-level study than invasive disease.
The findings could eventually help clinicians tell which DCIS diagnoses carry a higher risk of becoming invasive, which may shape decisions about monitoring versus treatment. For now, the research has not changed how DCIS is diagnosed or treated.
The takeaway
Not every DCIS diagnosis leads to invasive cancer, so the goal is to learn which lesions need aggressive action. Patients with a DCIS diagnosis should keep discussing monitoring and treatment options with their own clinicians.
Further reading
For more on how breast cancer is detected and tracked, explore the Cancer section on Wisevoter.
More information
Read the full published study in Science on the DCIS tumor microenvironment atlas.
Source note: This article includes information reported by News-Medical.
